Brentuximab Vedotin for Relapsed or Refractory Sézary Syndrome.

Saved in:
Bibliographic Details
Title: Brentuximab Vedotin for Relapsed or Refractory Sézary Syndrome.
Authors: Lewis DJ; Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia., Haun PL; Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia., Samimi SS; Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia., Vittorio CC; Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia., Villasenor-Park J; Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia., Barta SK; Abramson Cancer Center, Department of Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia., Landsburg DJ; Abramson Cancer Center, Department of Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia., Svoboda J; Abramson Cancer Center, Department of Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia., Nasta SD; Abramson Cancer Center, Department of Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia., Schuster SJ; Abramson Cancer Center, Department of Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia., Rook AH; Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia., Kim EJ; Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.
Source: JAMA dermatology [JAMA Dermatol] 2021 Mar 01; Vol. 157 (3), pp. 317-321.
Publication Type: Journal Article
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101589530 Publication Model: Print Cited Medium: Internet ISSN: 2168-6084 (Electronic) Linking ISSN: 21686068 NLM ISO Abbreviation: JAMA Dermatol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2168-6084
DOI:10.1001/jamadermatol.2020.4901